Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation

• Michał Bartkowski,
• Francesco Calzaferri and
• Silvia Giordani

Beilstein J. Nanotechnol. 2025, 16, 2092–2104, doi:10.3762/bjnano.16.144

• biological models. Determining the appropriate dosage is another crucial factor as therapeutic performance is influenced by drug loading capacity, drug release kinetics, and loading efficiency. Careful optimisation of these parameters is required to achieve effective drug delivery while minimising harm to

• provide insight into drug release kinetics based on NM properties and formulation. Animal toxicity studies help determine in vivo safety profiles across organ systems, while biodistribution and pharmacokinetic studies elucidate how CNMs are metabolised, cleared, and accumulate in the body, guiding safe

Beyond the shell: exploring polymer–lipid interfaces in core–shell nanofibers to carry hyaluronic acid and β-caryophyllene

• Aline Tavares da Silva Barreto,
• Francisco Alexandrino-Júnior,
• Bráulio Soares Arcanjo,
• Paulo Henrique de Souza Picciani and
• Kattya Gyselle de Holanda e Silva

Beilstein J. Nanotechnol. 2025, 16, 2015–2033, doi:10.3762/bjnano.16.139

• scaffolds remains challenging, as modifications that improve release kinetics or protect the core can sometimes compromise biocompatibility or cellular interactions [55]. To evaluate the structure of the nanofibers produced, confocal microscopy was used under a fluorescent filter to study the morphologies

• surface distribution may compromise encapsulation efficiency and alter release kinetics [76]. Surface hydrophilicity The hydrophilicity of the membranes was evaluated through contact angle measurements. Figure 10 shows photographs of a water droplet in contact with the surface of the samples: (a

• nanofibers in tissue engineering and controlled drug delivery. Despite these promising results, the present study has some limitations. The encapsulation efficiency and release kinetics of the bioactive compounds were not quantified, and biological assessments were not performed at this stage. Furthermore

Exploring the potential of polymers: advancements in oral nanocarrier technology

• Rousilândia de Araujo Silva,
• Igor Eduardo Silva Arruda,
• Luise Lopes Chaves,
• Mônica Felts de La Roca Soares and
• Jose Lamartine Soares Sobrinho

Beilstein J. Nanotechnol. 2025, 16, 1751–1793, doi:10.3762/bjnano.16.122

• made PNs a topic of growing interest in light of their small size and unique physicochemical properties [22][23]. These systems offer advantages for drug delivery, including the ability to protect labile compounds, control release kinetics, improve drug solubility and stability, enhance oral

• overall release kinetics [24][32][33]. From a pharmacokinetic perspective, the size, surface charge, and morphology of PNs can modulate their transit through the GIT, and such properties can be tuned during nanoparticle preparation. The choice of manufacturing method considers not only these parameters

Venom-loaded cationic-functionalized poly(lactic acid) nanoparticles for serum production against Tityus serrulatus scorpion

• Philippe de Castro Mesquita,
• Karla Samara Rocha Soares,
• Manoela Torres-Rêgo,
• Emanuell dos Santos-Silva,
• Mariana Farias Alves-Silva,
• Alianda Maira Cornélio,
• Matheus de Freitas Fernandes-Pedrosa and
• Arnóbio Antônio da Silva-Júnior

Beilstein J. Nanotechnol. 2025, 16, 1633–1643, doi:10.3762/bjnano.16.115

• on the particle size; thus, small particles have a larger surface area for dissolution, providing faster release kinetics [39]. Uniformity of particle size is also important for the stability of the formulation, as well as for the choice of administration route. The intravenous and intramuscular

Ferroptosis induction by engineered liposomes for enhanced tumor therapy

• Alireza Ghasempour,
• Mohammad Amin Tokallou,
• Mohammad Reza Naderi Allaf,
• Mohsen Moradi,
• Hamideh Dehghan,
• Mahsa Sedighi,
• Mohammad-Ali Shahbazi and
• Fahimeh Lavi Arab

Beilstein J. Nanotechnol. 2025, 16, 1325–1349, doi:10.3762/bjnano.16.97

• , lipid peroxidation facilitation, and drug release kinetics. In the following section, we explore how these engineered liposomes contribute to ferroptosis induction and tumor therapy. 3.3 Applications and advancements in liposomal drug delivery systems Liposomes are highly promising nanocarriers for drug

Better together: biomimetic nanomedicines for high performance tumor therapy

• Imran Shair Mohammad,
• Gizem Kursunluoglu,
• Anup Kumar Patel,
• Hafiz Muhammad Ishaq,
• Cansu Umran Tunc,
• Dilek Kanarya,
• Mubashar Rehman,
• Omer Aydin and
• Yin Lifang

Beilstein J. Nanotechnol. 2025, 16, 1246–1276, doi:10.3762/bjnano.16.92

• as brain, liver, spleen, lungs, arterial walls for both immediate and sustained release. Their degradation and release kinetics can be controlled or manipulated by different methods and incorporation or conjugation of specific materials. Importantly, they mainly focus on different biomaterials, drug

Hydrogels and nanogels: effectiveness in dermal applications

• Jéssica da Cruz Ludwig,
• Diana Fortkamp Grigoletto,
• Daniele Fernanda Renzi,
• Wolf-Rainer Abraham,
• Daniel de Paula and
• Najeh Maissar Khalil

Beilstein J. Nanotechnol. 2025, 16, 1216–1233, doi:10.3762/bjnano.16.90

• nanocarriers, pharmacokinetic and pharmacodynamic parameters – such as size, release kinetics, and biodistribution of the encapsulated drug – must be carefully defined to maximize the efficacy of the system [65]. Such considerations are essential to obtain stable formulations with a controlled release profile

Aprepitant-loaded solid lipid nanoparticles: a novel approach to enhance oral bioavailability

• Mazhar Hussain,
• Muhammad Farooq,
• Muhammad Asad Saeed,
• Muhammad Ijaz,
• Sherjeel Adnan,
• Zeeshan Masood,
• Muhammad Waqas,
• Wafa Ishaq and
• Nabeela Ameer

Beilstein J. Nanotechnol. 2025, 16, 652–663, doi:10.3762/bjnano.16.50

• /chitosan-coated cyclodextrin nanocapsules in acidic and basic media [16]. There is increased wetting of amorphous APT after loading into SLNs with increased surface area leading to rapid and consistent release. Drug release kinetics The drug release data obtained from APT-CD-NP1 to APT-PX-NP8 were analyzed

• (equivalent to 2 mg APT) were placed in a dialysis bag sealed at both ends in dissolution medium. After specified time intervals, samples (5 mL) were taken, replaced with fresh medium and analyzed through UV spectrophotometry at λmax = 210 nm after proper dilution. The drug release kinetics were determined by

Engineered PEG–PCL nanoparticles enable sensitive and selective detection of sodium dodecyl sulfate: a qualitative and quantitative analysis

• Soni Prajapati and
• Ranjana Singh

Beilstein J. Nanotechnol. 2025, 16, 385–396, doi:10.3762/bjnano.16.29

• release kinetics. After copolymerization, the reaction is terminated by dissolving the resulting copolymer in DCM, a solvent that allows the copolymer to remain in solution. The solution is then precipitated in cold diethyl ether, which helps to remove unreacted monomers and other impurities. This

Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide

• Radmila Milenkovska,
• Nikola Geskovski,
• Dushko Shalabalija,
• Ljubica Mihailova,
• Petre Makreski,
• Dushko Lukarski,
• Igor Stojkovski,
• Maja Simonoska Crcarevska and
• Kristina Mladenovska

Beilstein J. Nanotechnol. 2025, 16, 229–251, doi:10.3762/bjnano.16.18

• higher cytotoxicity of the hybrid CN. Additional decrease in the viability of cells was observed when GBM cells pre-treated with the corresponding CNs were exposed to irradiation, which could be ascribed to changes in size, surface charge, and release kinetics of TMZ and to irradiation-induced changes in

• formulation, biopharmaceutics/release kinetics, and pharmacokinetics of TMZ. Also, surface functionalization attempts with multiple targeting ligands were made to deliver TMZ to the site of interest, exploiting the site-specific expression or overexpression of specific molecules on BBTB and GBM cells to

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• crucial for maintaining therapeutic drug levels over extended periods of time [20][21]. By adjusting the polymer composition and lipid matrix, researchers can fine-tune the release kinetics of phytochemicals, ensuring sustained therapeutic effects. This controlled release mechanism is particularly

Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis

• Damai Ria Setyawati,
• Fransiska Christydira Sekaringtyas,
• Riyona Desvy Pratiwi,
• A’liyatur Rosyidah,
• Rohimmahtunnissa Azhar,
• Nunik Gustini,
• Gita Syahputra,
• Idah Rosidah,
• Etik Mardliyati,
• Tarwadi and
• Sjaikhurrizal El Muttaqien

Beilstein J. Nanotechnol. 2024, 15, 1105–1116, doi:10.3762/bjnano.15.89

• the FDA up to 2019 [46]. They consist of PLGA microparticles, solid implants, and in situ gels; none of them is a PLGA NP formulation. This fact indicates that there are some challenges, including poor drug entrapment efficiency and drug release kinetics from PLGA nanoformulations [47]. Regarding

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications

• Shakhzodjon Uzokboev,
• Khojimukhammad Akhmadbekov,
• Ra’no Nuritdinova,
• Salah M. Tawfik and
• Yong-Ill Lee

Beilstein J. Nanotechnol. 2024, 15, 1077–1104, doi:10.3762/bjnano.15.88

Radiofrequency enhances drug release from responsive nanoflowers for hepatocellular carcinoma therapy

• Yanyan Wen,
• Ningning Song,
• Yueyou Peng,
• Weiwei Wu,
• Qixiong Lin,
• Minjie Cui,
• Rongrong Li,
• Qiufeng Yu,
• Sixue Wu,
• Yongkang Liang,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2024, 15, 569–579, doi:10.3762/bjnano.15.49

• release from CUR-Fe@MnO2 NFs in the simulated TME. Drug release kinetics model fitting was also performed. The Higuchi, Ritger–Peppas, zero-order, and first-order methods were used to fit the experimental data, and R2 and release constants were calculated, as shown in Table 1. Among them, the Higuchi

• model has the highest degree of fitting with the release of NFs in different simulated environments within 72 h, which indicates conformity with the Fick diffusion mechanism. Meanwhile, we found that RF heating does not affect the release kinetics model. Ritger–Peppas is a semiempirical model, and n is

Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

• Hsuan-Ang Tsai,
• Tsai-Miao Shih,
• Theodore Tsai,
• Jhe-Wei Hu,
• Yi-An Lai,
• Jui-Fu Hsiao and
• Guochuan Emil Tsai

Beilstein J. Nanotechnol. 2024, 15, 465–474, doi:10.3762/bjnano.15.42

• long-term transdermal release kinetics of DCS nanocrystals and commercial DCS. (A–E are patch formulation compositions loaded with nanocrystals or commercial DCS that have been described in the section "Preparation of DCS nanocrystals" (n = 3)). Preliminary test of DCS solution in the reservoir

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• external magnetic field. This finding is crucial for future studies on magnetic field-guided drug release and tumour treatment. Particularly, our research also investigates the effect of varying polymer ratios on drug release kinetics and photothermal efficiency, which was not addressed in the

• was also determined. Consequently, our study represents a novel contribution to the field by investigating the impact of polymer thickness on drug release, offering enhanced drug loading efficiency, improved magnetic properties, and pH-responsive drug release kinetics. Materials and Methods Materials

• differences in drug release kinetics; our nanostructures exhibit a higher drug release percentage at pH 5.5 (84.57%) compared to pH 7.4 (57.71%). This underscores the pH-responsive behaviour of our drug delivery system, which could potentially enhance drug delivery to tumour sites while minimizing off-target

Development and characterization of potential larvicidal nanoemulsions against Aedes aegypti

• Jonatas L. Duarte,
• Leonardo Delello Di Filippo,
• Anna Eliza Maciel de Faria Mota Oliveira,
• Rafael Miguel Sábio,
• Gabriel Davi Marena,
• Tais Maria Bauab,
• Cristiane Duque,
• Vincent Corbel and
• Marlus Chorilli

Beilstein J. Nanotechnol. 2024, 15, 104–114, doi:10.3762/bjnano.15.10

• of cymene and myrcene. Mathematical release kinetics models for nanoemulsions (Cym-NE, Myr-NE) and free terpenes (Cym-Sol and Myr-Sol). Average mortality of Aedes aegypti larvae after 24 h of exposure to the free monoterpenes and their nanoemulsion. Inhibitory concentrations 50 (IC50) of the NEs (Cym

Berberine-loaded polylactic acid nanofiber scaffold as a drug delivery system: The relationship between chemical characteristics, drug-release behavior, and antibacterial efficiency

• Le Thi Le,
• Hue Thi Nguyen,
• Liem Thanh Nguyen,
• Huy Quang Tran and
• Thuy Thi Thu Nguyen

Beilstein J. Nanotechnol. 2024, 15, 71–82, doi:10.3762/bjnano.15.7

• hydrophilic BBR NPs favorably concentrated on the surface of the nanofibers. The relationship between the wettability and the BBR-release behavior of BBR-loaded PLA nanofiber scaffolds will be reported in the following drug-release profiles. In vitro drug-release profiles and release kinetics In vitro release

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• impact specific drug release kinetics and increase biocompatibility [60]. Different biodegradable polymers have been used for the development of targeted PNPs for the treatment of leishmaniasis [102]. In this scenario, chitosan is an interesting polymer for NP synthesis due to its positive charge, which

Polymer nanoparticles from low-energy nanoemulsions for biomedical applications

• Santiago Grijalvo and
• Carlos Rodriguez-Abreu

Beilstein J. Nanotechnol. 2023, 14, 339–350, doi:10.3762/bjnano.14.29

• phase, but it is always smaller (ca. 25 nm from TEM) than the precursor nanoemulsion droplets, regardless of the PLGA concentration. DXM can be encapsulated with efficiencies higher than 88% for PLGA concentrations in the 0.5–4 wt % range. The drug release kinetics seems to be slower as the PLGA

Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics

• Sedat Ünal,
• Osman Doğan and
• Yeşim Aktaş

Beilstein J. Nanotechnol. 2022, 13, 1393–1407, doi:10.3762/bjnano.13.115

• surface have similar charge, resulting in repulsive forces between NPs and mucus layer [55]. Release kinetics studies There are several factors influencing the fate of therapeutical formulations. Release kinetics models are directly relevant for the efficacy and safety of the drugs [56]. Data obtained

• , first order, Higuchi, Korsmeyer–Peppas, Peppas–Sahlin, Hopfenberg, Baker–Lonsdale, or Weibull model). Many studies in this area only evaluate the in vitro release profile, but examining possible models in release kinetics, especially in oral drug delivery systems, is valuable for a clearer

• interpretation of release behavior. These quantitative evaluations help to accelerate the drug development processes by estimating the in vivo performance of formulations. The results of the release kinetics modelling studies are presented in Table 3 and Figure 5. In Figure 5, DCX release curves and the curves

Ethosomal (−)-epigallocatechin-3-gallate as a novel approach to enhance antioxidant, anti-collagenase and anti-elastase effects

• Çiğdem Yücel,
• Gökçe Şeker Karatoprak,
• Sena Yalçıntaş and
• Tuğba Eren Böncü

Beilstein J. Nanotechnol. 2022, 13, 491–502, doi:10.3762/bjnano.13.41

• release kinetics were investigated. The formulations used had PSs in the nanoscale range and drug encapsulation efficiency values were over 97.2% and 77% [34]. In our study, both the ETHs and ETHG systems have been proven to be effective and safe in treatments with the cell permeation rate and

Engineered titania nanomaterials in advanced clinical applications

• Padmavati Sahare,
• Paulina Govea Alvarez,
• Juan Manual Sanchez Yanez,
• Gabriel Luna-Bárcenas,
• Samik Chakraborty,
• Sujay Paul and
• Miriam Estevez

Beilstein J. Nanotechnol. 2022, 13, 201–218, doi:10.3762/bjnano.13.15

• demonstrated enhanced osseointegration [58]. Additionally, drug release kinetics and duration from titania nanotubes (TNTs) can be controlled by modifying nanotube dimensions, surface chemistry, or by a polymer coating on the TNT implant surface through dip coating or plasma polymerization. Losic and co

Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

• Sadaf Mushtaq,
• Khuram Shahzad,
• Tariq Saeed,
• Anwar Ul-Hamid,
• Bilal Haider Abbasi,
• Nafees Ahmad,
• Waqas Khalid,
• Muhammad Atif,
• Zulqurnain Ali and
• Rashda Abbasi

Beilstein J. Nanotechnol. 2021, 12, 1339–1364, doi:10.3762/bjnano.12.99

• applications [30]. All samples have lower PDI values (0.13–0.33) which indicates a uniform distribution of NPs in different dispersion media (Table 5). pH-dependent drug-loading and drug-release kinetics The UV–vis-based confirmation of drug (DOX and MTX) attachment to PMA-coated MFe2O4 (M = Fe, Co, Zn, Ni

• 0.5 mM of drugs for the loading on NPs. The encapsulated and loaded drug % for DOX and MTX are given in Table 6. For pH-dependent drug-release kinetics, drug-loaded NPs were dispersed in solutions with different pH values (1× PBS; pH 5.5, 6.5, and 7.4) at room temperature and the amount of release

• release kinetics Drug release kinetics of DOX- and MTX-loaded MFe2O4 (M = Fe, Co, Zn, Ni) NPs were studied at different pH values [68]. The nanoparticles were dispersed in PBS with pH values ranging from 5.5–7.4 and spectrophotometric data were measured at different time intervals (0, 1, 5, 10, 20, 40, 60

pH-driven enhancement of anti-tubercular drug loading on iron oxide nanoparticles for drug delivery in macrophages

• Karishma Berta Cotta,
• Sarika Mehra and
• Rajdip Bandyopadhyaya

Beilstein J. Nanotechnol. 2021, 12, 1127–1139, doi:10.3762/bjnano.12.84

• the release kinetics and saturation amounts were identical in both the pH (5 or 7.4) of the release media, irrespective of whether NOR@IONPpH5 or NOR@IONPpH10 was used (Figure 5). Free drug is observed to have rapid release profile which saturates by 4 h. NOR@IONPpH5 displays an initial burst release